Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
CEO: Daniel A. Perez. Company website
Hinge Health, Inc. (HNGE) trades at $94.90, up 0.19% on the day, as of Sep 20, 2026 14:57 UTC.
Hinge Health, Inc. has a market capitalisation of $7.34B, calculated from the live HNGE share price and shares outstanding.
HNGE trades at a trailing P/E of 73.57, from earnings per share of $1.29 over the last twelve months.
Hinge Health, Inc. generated revenue of $720.06M over the trailing twelve months, which puts the stock at 10.20 times sales.
HNGE has traded between $30.08 and $96.66 over the past 52 weeks, and the last price is 1.8% below that high.
Yes. Hinge Health, Inc. keeps 15.15% of revenue as net income over the trailing twelve months.
Wall Street analysts rate HNGE Buy, with an average price target of $98.92, 4.2% above the current price.
Hinge Health, Inc. is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US.
Daniel A. Perez is the chief executive of Hinge Health, Inc., which employs 1,437 people.
QFI Terminal shows HNGE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open HNGE in Terminal See plans